Vaccine Hesitancy Clinical Trial
Official title:
Randomized Controlled Trial Of A Health Belief Model-Based Intervention To Prompt To Take Up The Childhood Vaccines And Effect On Vaccination Attitudes
NCT number | NCT05425823 |
Other study ID # | 221430001 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 4, 2022 |
Est. completion date | January 19, 2024 |
Verified date | February 2024 |
Source | Necmettin Erbakan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to determine the effect of pregnant women aged 18 years and older who have completed their 28th week of pregnancy and received intervention based on the Health Belief Model, on encouraging childhood vaccinations and influencing their vaccination attitudes, compared to pregnant women who receive standard care group. The 12-month vaccination rate of newborns and the change in their attitudes will be determined according to the Public Attitude Towards Vaccination Scale - Health Belief Model.
Status | Completed |
Enrollment | 54 |
Est. completion date | January 19, 2024 |
Est. primary completion date | December 30, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - The pregnant woman and her spouse are Turkish literate, - Completing the 28th week of pregnancy, - Desire to participate in the study, - The pregnant's spouse has any type of mobile phone. Exclusion Criteria: - The pregnant woman has any mental problem that causes learning difficulties or has been diagnosed (if detected in the pregnancy outpatient clinic record). - 38 weeks of pregnancy and above - Living outside of the 3 central districts of Konya (Selçuklu, Meram, Karatay) |
Country | Name | City | State |
---|---|---|---|
Turkey | Necmettin Erbakan University | Konya | Konya/MEram |
Lead Sponsor | Collaborator |
---|---|
Necmettin Erbakan University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Children's vaccination rates 1st | Childhood vaccination rates of intervention groups and standard care group in the study were similar at the end of the 1st month. | 1.month | |
Primary | Children's vaccination rates 6th | Childhood vaccination rates of intervention groups and standard care group in the study were similar at the end of the 6th month. | 6th.month | |
Primary | Children's vaccination rates 12th | Childhood vaccination rates of intervention groups and standard care group in the study were similar at the end of the 12th months. | 12.month | |
Secondary | Scores from the Public Attitude Towards Vaccination Scale - Health Belief Model | The Public Attitude Towards Vaccination Scale-Health Belief Model sub-dimensions (severity, susceptibility, benefit, barrier, health motivation) scores of the intervention groups (1 and 2) were similar the standard care group's at the 1st months postpartum.
Evaluation of the scale cannot be made over the total score. It consists of a total of 26 questions and 5 sub-dimensions. When all five sub-dimensions and sub-dimensions with a five-point Likert response are evaluated separately; Susceptibility and severity sub-dimension consists of 4 items (lowest 4, highest 20 points), benefit and health responsibility sub-dimension 5 items (lowest 5 points, highest 25 points), barrier sub-dimension consists of 8 items (lowest 8, highest 40 points). While a decrease in the score in the obstacle sub-dimension indicates a positive attitude, an increase in the score in the other sub-dimensions indicates a positive attitude. |
1.month | |
Secondary | Scores from the Public Attitude Towards Vaccination Scale - Health Belief Model | The Public Attitude Towards Vaccination Scale-Health Belief Model sub-dimensions (severity, susceptibility, benefit, barrier, health motivation) scores of the intervention groups (1 and 2) were similar the standard care group's at the 6th months postpartum.
Evaluation of the scale cannot be made over the total score. It consists of a total of 26 questions and 5 sub-dimensions. When all five sub-dimensions and sub-dimensions with a five-point Likert response are evaluated separately; Susceptibility and severity sub-dimension consists of 4 items (lowest 4, highest 20 points), benefit and health responsibility sub-dimension 5 items (lowest 5 points, highest 25 points), barrier sub-dimension consists of 8 items (lowest 8, highest 40 points). While a decrease in the score in the obstacle sub-dimension indicates a positive attitude, an increase in the score in the other sub-dimensions indicates a positive attitude. |
6.month | |
Secondary | Scores from the Public Attitude Towards Vaccination Scale - Health Belief Model | The Public Attitude Towards Vaccination Scale-Health Belief Model sub-dimensions (severity, susceptibility, benefit, barrier, health motivation) scores of the intervention groups (1 and 2) were similar the standard care group's at the 12th months postpartum.
Evaluation of the scale cannot be made over the total score. It consists of a total of 26 questions and 5 sub-dimensions. When all five sub-dimensions and sub-dimensions with a five-point Likert response are evaluated separately; Susceptibility and severity sub-dimension consists of 4 items (lowest 4, highest 20 points), benefit and health responsibility sub-dimension 5 items (lowest 5 points, highest 25 points), barrier sub-dimension consists of 8 items (lowest 8, highest 40 points). While a decrease in the score in the obstacle sub-dimension indicates a positive attitude, an increase in the score in the other sub-dimensions indicates a positive attitude. |
12.month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05994820 -
Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India
|
N/A | |
Completed |
NCT05537441 -
Precision Vaccine Promotion in Underserved Populations
|
N/A | |
Recruiting |
NCT05998824 -
COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease
|
N/A | |
Terminated |
NCT05167422 -
Trusted Messenger Intervention
|
N/A | |
Completed |
NCT04939506 -
COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana
|
N/A | |
Recruiting |
NCT05787015 -
Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy
|
N/A | |
Enrolling by invitation |
NCT06062056 -
Motivational Interviewing for Vaccine Uptake in Latinx Adults
|
N/A | |
Recruiting |
NCT05473936 -
A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination
|
N/A | |
Not yet recruiting |
NCT05531058 -
The Impact of a Web-based Psychoeducation Programme With a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy
|
N/A | |
Not yet recruiting |
NCT05120817 -
Emphasizing the Personal Versus the Social in Educational Interventions For Decreasing Vaccine Hesitancy
|
N/A | |
Completed |
NCT05206669 -
Testing Messages to Promote HPV Vaccination
|
N/A | |
Completed |
NCT06155877 -
Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents
|
N/A | |
Completed |
NCT06124131 -
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
|
N/A | |
Recruiting |
NCT06417762 -
Dime La VerDAD: Verify, Debunk, and Disseminate
|
N/A | |
Recruiting |
NCT06297876 -
COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color
|
N/A | |
Enrolling by invitation |
NCT06156228 -
Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
|
N/A | |
Recruiting |
NCT05042011 -
Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study
|
||
Not yet recruiting |
NCT06374134 -
The Impact of Community and Patient Engagement Practices on Vaccine Confidence in the United States
|
||
Completed |
NCT01385501 -
Educational Intervention to Improve Vaccine Acceptance
|
N/A | |
Completed |
NCT05582564 -
The Effect of Newspaper Reporting on COVID-19 Vaccine Hesitancy: a Randomised Controlled Trial
|
N/A |